rss
Br J Ophthalmol 2007;91:427-429 doi:10.1136/bjo.2006.105098
  • Clinical science
    • Scientific reports

Urrets-Zavalia syndrome as a complication of argon laser peripheral iridoplasty

  1. E M Espana1,
  2. A Ioannidis2,
  3. C Tello1,
  4. J M Liebmann3,
  5. P Foster2,
  6. R Ritch4
  1. 1Department of Ophthalmology, The New York Eye and Ear Infirmary, New York, New York, USA
  2. 2Institute of Ophthalmology, University College London, London, UK
  3. 3New York University School of Medicine, New York, New York, USA; Manhattan Eye, Ear and Throat Hospital, New York, New York, USA
  4. 4The New York Medical College, Valhalla, New York, USA
  1. Correspondence to: Professor R Ritch Glaucoma Service, Department of Ophthalmology, The New York Eye and Ear Infirmary, 310 East 14th Street, New York, NY 10003, USA; ritchmd{at}earthlink.net
  • Accepted 9 September 2006
  • Published Online First 20 September 2006

Abstract

Objective: To report on 8 patients who developed prolonged mydriasis after argon laser peripheral iridoplasty (ALPI).

Design: Retrospective case series.

Methods: A review of the charts of 8 patients with persistent occludable angles after laser iridotomy who developed mydriasis after undergoing ALPI.

Results: 12 eyes of 8 patients (mean age 50.2, standard deviation 6.9, range 40–61 years) developed persistent dilatation. 7 of 8 patients had plateau iris syndrome. Only one patient had a decrease in visual acuity. Intraocular pressure increased only in 1 eye and remained stable or decreased in the others. Of the 8 patients, 7 had blurred vision, 2 had photophobia, 4 had glare and 1 had discomfort. The pupillary response to pilocarpine instillation was minimal or absent. Mydriasis eventually resolved in all eyes without treatment.

Conclusion: ALPI can be complicated by mydriasis unresponsive to pilocarpine. Mydriasis and accompanying symptoms resolved spontaneously within 1 year in most patients.

Footnotes

  • Funding: This study was supported by the Norman and Sandra Pessin Research Fund of the New York Glaucoma Research Institute, New York, New York, USA

  • Competing interests: None.

  • Published Online First 20 September 2006

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. bjo.2006.105098v1
    2. 91/4/427 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.